Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

652

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Chronic Non-specific Low Back Pain
Interventions
DRUG

VER-01

"Herbal medicinal product, containing as active substance a soft extract of Cannabis sativa L., cannabis flos (Cannabis flower), adjusted to a content of 50 mg/g delta-9-tetrahydrocannabinol (THC).~VER-01 is adjusted to a concentration of 19 mg/mL THC by adding the excipient sesame oil."

DRUG

Placebo

Comparator without active ingredient

Trial Locations (1)

Unknown

St Pancras Clinical Research, London

All Listed Sponsors
lead

Vertanical GmbH

INDUSTRY

NCT06475001 - Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain | Biotech Hunter | Biotech Hunter